SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia shares are under pressure amid its boards investigation into CEO Jensen Huangs admitted affair with a businesswoman alleged to have ties to Chinese intelligence, raising speculation about national-security scrutiny and Huangs job security. Traders are split between fearing leadership disruption or further damaging disclosures and viewing the controversy as separate from Nvidias business and a buying opportunity.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

A sharp selloff ahead of Hims & Hers Q3 results has traders debating whether the weakness reflects concern about the report or simply volatile positioning; unverified earnings-leak claims are speculation, not confirmed news. Bulls cite the Eli Lilly obesity-drug partnership and growth prospects, while bears focus on potential margin pressure and the outlook.

XRP (XRP) is a cryptocurrency . XRP has a current supply of 99,985,583,260 with 63,516,606,953 in circulation. The last known price of XRP is 1.11892236 USD and is down -3.62 over the last 24 hours. It is currently trading on 1894 active market(s) with $1,884,610,999.15 traded over the last 24 hours. More information can be found at https://xrpl.org/.

Ripple

XRPs steep decline alongside a broader crypto selloff has traders focused on whether it will break below the $1 level, with some attributing pressure to market liquidations and uncertainty around crypto regulation and the CLARITY Act. Bearish calls for further losses and frustration over XRPs weak performance compete with holders buying the dip and arguing the token is near a bottom.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMDs rally is being tied to an Oppenheimer upgrade and Googles use of AMD EPYC processors in its new AI infrastructure, reinforcing the companys data-center growth story. Traders also speculate that Nvidias CEO controversy is prompting a rotation into AMD, though some question the valuation and warn the sharp move could fade.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. The firm operates through the following geographical segments: United States and International. It offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

A sharp, high-volume run-up ahead of Trade Desks Q3 earnings has put the report in focus, with traders speculating about short covering and an unverified earnings leak. Bulls see room for a rebound, while skeptics warn that weak ad-growth expectations could erase the gains and question whether to hold through the release.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

A sharp rally in small caps has put IWM in focus, with traders attributing the move to a possible short squeeze and rotation into the Russell 2000. Bulls welcome the momentum, while skeptics question the rallys light volume and weak inflows and warn it may fade; CPI and Iran-deal speculation add uncertainty.

Take-Two Interactive Software, Inc. engages in the development, publishing, and marketing of interactive software games. Its products are designed for console systems, handheld gaming systems, and personal computers, including smart phones and tablets, and are delivered through physical retail, digital download, online platforms, and cloud streaming services. The company was founded by Ryan A. Brant in 1993 and is headquartered in New York, NY.

Take-Two Interactive Software, Inc.

Take-Twos earnings report ahead of the scheduled GTA VI launch is driving attention, with traders focused on managements guidance and whether it will provide preorder details. Many expect the blockbuster game and its online monetization to boost the business, while others warn that high expectations may already be priced in and the stock could fall on cautious commentary or a sell-the-news reaction.

Churchill Capital Corp. XI is a blank check company. It was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Michael Stuart Klein on June 4, 2025 and is headquartered in New York, NY.

Agility Robotics Inc.

Agility Robotics Inc. - Ordinary Shares - Class A

AGLT is drawing attention after a sharp post-merger selloff, with traders blaming typical de-SPAC selling and questioning the companys finances, profitability, and valuation ahead of a financial report. Some see the weakness as a chance to accumulate, citing Agilitys humanoid-robot orders and long-term potential, while others remain bearish on the SPAC and its execution risks.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics BRIUMVI growth drove a third-quarter revenue beat and higher full-year guidance, but the share-price pullback despite the results has fueled a sell the news debate. Traders are also focused on Phase 3 data for a subcutaneous BRIUMVI formulation as a future catalyst.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricors pending FDA decision on deramiocel for Duchenne muscular dystrophy is driving attention, with traders focused on the Nov. 22 PDUFA date and HOPE-3 upper-limb results. Bulls cite the trial data and support from treating physicians, while skeptics emphasize FDA concerns and the risk of a rejection; whether any approval would also cover cardiac benefits remains debated.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CF Q3 Earnings Miss Estimates as Higher Costs Offset Sales Gains

CF Industries' Q3 2026 earnings miss estimates despite a 12.1% sales gain, as higher costs weigh on profitability.

CF (CF) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for CF (CF) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

CF Industries (CF) Q3 Earnings Lag Estimates

CF (CF) delivered earnings and revenue surprises of -2.05% and +5.64%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

CF Industries Holdings, Inc. Reports First Nine Months 2026 Net Earnings of $1.78 Billion, Adjusted EBITDA of $3.01 Billion

CF Industries Holdings, Inc. (NYSE: CF), a leading global manufacturer of hydrogen and nitrogen products, today announced results for the nine months and third quarter ended September 30, 2026. Highlights First nine months 2026 net earnings(1) of $1.78 billion, or $11.60 per diluted share...

Intrepid Potash (IPI) Q3 Earnings and Revenues Beat Estimates

Intrepid Potash (IPI) delivered earnings and revenue surprises of +7.69% and +2.06%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

ALB to Report Q3 Earnings: What's in the Offing for the Stock?

ALB heads into Q3 earnings with cost savings and productivity gains offering support, while lithium price weakness and Energy Storage volume pressures pose challenges.

Here's Why CF Industries (CF) is a Strong Value Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

CF Industries (CF) is a Top-Ranked Momentum Stock: Should You Buy?

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

CF Industries (CF) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

CF (CF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Here's How Much $100 Invested In CF Industries Holdings 20 Years Ago Would Be Worth Today

CF Industries Holdings (NYSE:CF) has outperformed the market over the past 20 years by 6.48% on an annualized basis producing an average annual return of 15.42%. Currently, CF Industries Holdings has a marketread more...

• Reported GAAP EPS of $2.87 up 31.05% YoY
• Reported revenue of $1.86B up 12.12% YoY
• CF Industries projects full-year 2026 capital expenditures of approximately $1.3B, or approximately $950M excluding JERA and Mitsui-funded amounts; gross ammonia production is expected to be approximately 9.5M.

CF Industries Yazoo City production loss reduced AN volumes; third-quarter cost of sales was higher due to purchased products, freight, distribution and maintenance, and filing cites cyclical markets and intense global competition.

CF Industries reported higher third-quarter sales, earnings and adjusted EBITDA versus 2025; nitrogen prices increased amid constrained supply, while Blue Point One construction commenced in August.

CF Industries Holdings, Inc. engages in the manufacture and distribution of nitrogen fertilizer. The firm owns and operates nitrogen plants and serves agricultural and industrial customers through its distribution system. It operates through the following segments: Ammonia, Granular Urea, UAN, AN, and Other. The Ammonia segment produces anhydrous ammonia. The Granular Urea segment offers granular urea. The UAN segment focuses on urea ammonium nitrate solution. The AN segment refers to the production of ammonium nitrate. The Other segment includes diesel exhaust fluid, nitric acid, urea liquor, and aqua ammonia. The company was founded in 1946 and is headquartered in Northbrook, IL.

CF Industries Holdings Inc

Has CF Stock Topped Out? How US-Iran Ceasefire Erodes Key Competitive Edge For Fertilizer Maker

Equity

Bullish Sentiment

representational image of a tractor spraying fertilizers in the farm field

Shares of CF Industries dipped after the U.S.-Iran ceasefire, raising doubts about the persistence of Iranian energy export disruptions that had been boosting the company's competitive position.

Nutrien Ltd

Buying the dip

Selling or trimming

Holding

Waiting for the investigation results to decide

Nvidia ($NVDA) is down about 4% after its board opened an investigation into CEO Jensen Huang. What are you doing with the stock?

Stocktwits

) is down about 4% after its board opened an investigation into CEO Jensen Huang. What are you doing with the stock?

Current Price	$120.20
Prev Close	$119.39
Open	$118.75
Dividend Yield	2.59%
50-Day Moving Average	$122.43
Beta	-0.00
Avg. Volume	2.23M
PE Ratio	8.43

52-Week High	$141.96
52-Week Low	$75.42
Market Capitalization	$17.46B
EPS (Annual)	$8.97
Price to Book	3.10
Revenue Per Employee	$2.44M

Feed

News

Sentiment

Earnings

Fundamentals

Info

CF Fundamentals